市场调查报告书
商品编码
1497880
经肠营养製剂市场:按产品、类别、应用、分销管道和最终用户 - 2024-2030 年全球预测Enteral Feeding Formulas Market by Product (Disease-Specific Formulas, Standard Formulas), Category (Adult Formula, Pediatric Formula), Application, Distribution Channel, End-Users - Global Forecast 2024-2030 |
※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。
经肠营养製剂市场规模预计2023年为61亿美元,预计2024年将达到65.9亿美元,2030年将达到105.4亿美元,复合年增长率为8.11%。
经肠营养配方食品是专为无法口服食物但胃肠道功能正常的人设计的饮食治疗方法。这些製剂透过管子直接输送到胃和肠,用于提供完整或补充营养。这种专门的营养补充对于患有严重疾病、吞嚥困难、胃肠功能障碍或手术后恢復的患者至关重要,可以可靠地摄取改善或维持健康所需的必需营养素。世界上不断增长的老年人口,更容易患慢性疾病和疾病,增加了对经肠营养製剂的需求。医疗保健提供者和患者对经肠营养益处的认识不断提高,包括其在促进康復过程和减少住院时间方面的作用,正在推动经肠营养製剂市场的成长。在某些情况下对肠外营养的日益偏好正在阻碍市场成长。配方和输送系统的不断改进使经肠营养产品更安全、更有效率,这为经肠营养配方创造了成长机会。
主要市场统计 | |
---|---|
基准年[2023] | 61亿美元 |
预测年份 [2024] | 65.9亿美元 |
预测年份 [2030] | 105.4亿美元 |
复合年增长率(%) | 8.11% |
区域洞察
在美洲,由于先进的医疗基础设施、慢性病的高盛行率以及人口老化的加剧,经肠营养市场高度发达,所有这些都需要使用经肠营养解决方案。此外,该地区显着采用了技术先进的产品和严格的指导方针,确保经肠营养的高品质标准,进一步推动市场成长。由于人们对经肠营养益处的认识不断提高、医疗保健支出不断增加以及全部区域医疗保健设施的改善,亚太地区经肠营养製剂市场正在快速成长。在中国和印度等人口众多的国家,患有慢性疾病和营养不良的患者数量正在迅速增加,增加了对经肠营养製剂的需求。欧洲、中东和非洲地区呈现多元化的市场格局。欧洲因其完善的医疗保健系统、慢性病患病率高以及主要经肠营养製造商的强大影响力而在该地区处于领先地位。由于医疗基础设施投资增加和临床营养意识不断增强,中东和非洲市场显示出成长潜力。
FPNV定位矩阵
FPNV 定位矩阵对于评估供应商在经肠营养製剂市场的定位至关重要。此矩阵提供了对供应商的全面评估,并检验了与商务策略和产品满意度相关的关键指标。这种详细的评估使用户能够根据自己的要求做出明智的决定。根据评估结果,供应商被分为代表其成功程度的四个像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市场占有率分析
市场占有率分析是一种综合工具,可以对经肠营养产品市场供应商的现状进行深入而详细的评估。透过仔细比较和分析供应商的贡献,您可以更深入地了解每个供应商的绩效以及他们在争夺市场占有率时面临的挑战。这些贡献包括整体收益、客户群和其他重要指标。此外,该分析还提供了对该行业竞争性质的宝贵见解,包括在研究基准年期间观察到的累积、分散主导地位和合併特征等因素。有了这些详细信息,供应商可以做出更明智的决策并製定有效的策略,以在市场竞争中保持领先地位。
策略分析与建议
策略分析对于寻求在全球市场站稳脚跟的组织至关重要。对经肠营养製剂市场当前地位的全面评估使公司能够做出符合其长期愿望的明智决策。此关键评估涉及对组织的资源、能力和整体绩效进行彻底分析,以确定核心优势和需要改进的领域。
[187 Pages Report] The Enteral Feeding Formulas Market size was estimated at USD 6.10 billion in 2023 and expected to reach USD 6.59 billion in 2024, at a CAGR 8.11% to reach USD 10.54 billion by 2030.
Enteral feeding formulas are dietary solutions designed for individuals who are unable to consume food orally but have a functioning digestive tract. These formulas are delivered through tubes directly into the stomach or intestine and are formulated to provide complete or supplemental nutrition. This specialized nutrition support is critical for patients who are critically ill, have swallowing difficulties, or gastrointestinal dysfunction, or are recovering from surgery, ensuring they receive the necessary nutrients to improve or maintain their health. The global increase in the elderly population who are prone to chronic conditions and diseases is necesistating the need for enteral feeding formulas. Growing awareness among healthcare providers and patients about the benefits of enteral nutrition, including its role in enhancing the recovery process and reducing hospital stays is driving the growth of the enteral feeding formulas market. Growing preference for parenteral nutrition in certain conditions hampers the growth of the market. Ongoing improvements in the formulation and delivery systems of enteral feeding products that make them safer and more efficient are creating opportunities for the growth of enteral feeding formulas.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 6.10 billion |
Estimated Year [2024] | USD 6.59 billion |
Forecast Year [2030] | USD 10.54 billion |
CAGR (%) | 8.11% |
Regional Insights
In the Americas, the market for eternal feeding is highly developing due to its advanced healthcare infrastructure, high prevalence of chronic diseases, and growing aging population, all of which necessitate the use of enteral feeding solutions. Additionally, the region observes a significant adoption of technologically advanced products and has stringent guidelines ensuring high-quality standards for enteral nutrition, further driving the market growth. The APAC region is witnessing rapid growth in the enteral feeding formulas market, attributed to the rising awareness about the benefits of enteral nutrition, increasing healthcare spending, and improvements in healthcare facilities across the region. Countries including China and India, with their large populations, are seeing a surge in the number of patients suffering from chronic conditions and malnutrition, which boosts the need for enteral feeding formulas. The EMEA region exhibits a diverse market landscape. Europe leads in the region due to its well-established healthcare systems, high prevalence of chronic diseases, and strong presence of leading enteral formula manufacturers. The market in the Middle East and Africa shows potential for growth due to increasing investments in healthcare infrastructure and growing awareness about clinical nutrition.
Market Insights
The market dynamics represent an ever-changing landscape of the Enteral Feeding Formulas Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.
FPNV Positioning Matrix
The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Enteral Feeding Formulas Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Enteral Feeding Formulas Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Recent Developments
Vygon Introduces Innovative Nutrisafe2 Feeding System for Enhanced Neonatal Care
Vygon launched the Nutrisafe2 feeding system, specifically engineered to meet the delicate nutritional needs of neonates. This advanced system is designed to offer a safer, more accurate method of enteral feeding for newborns, addressing the critical importance of nutrition during the early stages of life. The Nutrisafe2 system is distinguished by its unique safety features that minimize the risks associated with enteral feeding practices, such as misconnections and the inadvertent delivery of incorrect nutritional doses. [Published On: 2024-03-18]
Kate Farms Introduces Whole Food-Based Enteral Feeding Solutions
Kate Farms introduced whole-food blended meals specifically designed for enteral feeding, presented in user-friendly, resealable pouches. This development is noteworthy as these pouches are engineered to seamlessly connect with commonly used tube feeding devices, promoting ease of use. The product line epitomizes a blend of nutritional science and convenience, catering to the essential dietary needs of individuals dependent on tube feeding for sustenance. [Published On: 2023-11-01]
Nestle Health Science Invests USD 43 Million in Advanced Enteral Feeding Formula Facility
Nestle Health Science is significantly enhancing its manufacturing capabilities in Eau Claire, Wisconsin, through a substantial USD 43 million investment. This strategic financial infusion aims to expand and upgrade the facility's operations, particularly focusing on producing enteral feeding formulas. These specialized nutritional solutions are essential in medical settings, providing vital nourishment for patients unable to consume food orally. [Published On: 2023-01-18]
Strategy Analysis & Recommendation
The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Enteral Feeding Formulas Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.
Key Company Profiles
The report delves into recent significant developments in the Enteral Feeding Formulas Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories Ltd, B. Braun SE, Danone S.A., Fresenius Kabi AG, Global Health Products, Inc., Hormel Foods Corporation, Johnson & Johnson Services, Inc, Kate Farms, Inc., Medline Industries, Inc., Medtrition, Inc., Meiji Holdings Co., Ltd, Nestle SA, Nutricia North America, Otsuka Holdings Co., Ltd, Primus Pharmaceuticals, Inc., Real Food Blends by Nutrica, Reckitt Benckiser Group plc., and Victus, Inc..
Market Segmentation & Coverage